{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T14:08:42Z","timestamp":1795010922264,"version":"4.9.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13054-017-1856-1","type":"journal-article","created":{"date-parts":[[2017,11,14]],"date-time":"2017-11-14T11:24:55Z","timestamp":1510658695000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":333,"title":["Cefepime-induced neurotoxicity: a systematic review"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6997-4853","authenticated-orcid":false,"given":"Lauren E.","family":"Payne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Gagnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard R.","family":"Riker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Seder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth K.","family":"Glisic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane G.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles L.","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,14]]},"reference":[{"key":"1856_CR1","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1093\/ndt\/14.9.2265","volume":"14","author":"KM Wong","year":"1999","unstructured":"Wong KM, Chan WK, Chan YH, Li CS. Cefepime-related neurotoxicity in a haemodialysis patient. Nephrol Dial Transplant. 1999;14:2265\u20136.","journal-title":"Nephrol Dial Transplant"},{"key":"1856_CR2","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1093\/jac\/dks012","volume":"67","author":"C Durand-Maugard","year":"2012","unstructured":"Durand-Maugard C, Lemaire-Hurtel AS, Gras-Champel V, Hary L, Maizel J, Prud\u2019homme-Bernardy A, et al. Blood and CSF monitoring of cefepime-induced neurotoxicity: nine case reports. J Antimicrob Chemother. 2012;67:1297\u20139.","journal-title":"J Antimicrob Chemother"},{"key":"1856_CR3","unstructured":"Cefepime [package insert] Bristol-Myers Squibb Company, Princeton, NJ; 2016. Accessed Nov 2016. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/050679s036lbl.pdf ."},{"key":"1856_CR4","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1128\/AAC.01595-08","volume":"54","author":"F Lamoth","year":"2010","unstructured":"Lamoth F, Buclin T, Pascual A, Vora S, Bolay S, Decosterd L, et al. High cefepime plasma concentrations and neurological toxicity in febrile neutropenic patients with mild impairment of renal function. Antimicrob Agents Chemother. 2010;54:4360\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"1856_CR5","doi-asserted-by":"crossref","first-page":"R264","DOI":"10.1186\/cc13094","volume":"17","author":"JE Fugate","year":"2013","unstructured":"Fugate JE, Kalimullah EA, Hocker SE, Clark SL, Wijdicks EF, Rabinstein AA. Cefepime neurotoxicity in the intensive care unit: a cause of severe, underappreciated encephalopathy. Crit Care. 2013;17:R264.","journal-title":"Crit Care"},{"key":"1856_CR6","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00134-014-3641-9","volume":"41","author":"M Carlier","year":"2015","unstructured":"Carlier M, Dumoulin A, Janssen A, Picavet S, Vanthuyne S, Van Eynde R, et al. Comparison of different equations to assess glomerular filtration in critically ill patients. Intensive Care Med. 2015;41:427\u201335.","journal-title":"Intensive Care Med"},{"key":"1856_CR7","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/1471-2369-14-250","volume":"14","author":"A Udy","year":"2013","unstructured":"Udy A, Morton J, Nguyen-Pham S, Jarrett P, Lassig-Smith M, Stuart J, et al. A comparison of CKD-EPI estimated glomerular filtration rate and measured creatinine clearance in recently admitted critically ill patients with normal plasma creatinine concentrations. BMC Nephrol. 2013;14:250.","journal-title":"BMC Nephrol"},{"key":"1856_CR8","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1345\/aph.1L307","volume":"42","author":"MF Grill","year":"2008","unstructured":"Grill MF, Maganti R. Cephalosporin-induced neurotoxicity: clinical manifestations, potential pathogenic mechanisms, and the role of electroencephalographic monitoring. Ann Pharmacother. 2008;42:1843\u201350.","journal-title":"Ann Pharmacother"},{"key":"1856_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","volume":"4","author":"D Moher","year":"2015","unstructured":"Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1.","journal-title":"Syst Rev"},{"key":"1856_CR10","doi-asserted-by":"crossref","unstructured":"Huwyler T, Lenggenhager L, Abbas M, Lorenzini KI, Hughes S, et al. Cefepime plasma concentrations and clinical toxicity: a retrospective cohort study. Clin Microbiol Infect. 2017;7:454\u201359.","DOI":"10.1016\/j.cmi.2017.01.005"},{"key":"1856_CR11","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.7326\/0003-4819-135-11-200112040-00027","volume":"135","author":"F Barbey","year":"2001","unstructured":"Barbey F, Bugnon D, Wauters JP. Severe neurotoxicity of cefepime in uremic patients. Ann Intern Med. 2001;135:1011.","journal-title":"Ann Intern Med"},{"key":"1856_CR12","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s13054-016-1394-2","volume":"20","author":"F May","year":"2016","unstructured":"May F, El-Helali J, Timsit JF, Misset B. Absence of obvious link between supra-therapeutic serum levels of beta lactams and clinical toxicity in ICU patients with acute renal failure treated with intermittent hemodialysis. Crit Care. 2016;20:220.","journal-title":"Crit Care"},{"key":"1856_CR13","first-page":"526","volume":"21","author":"EO Garces","year":"2008","unstructured":"Garces EO, de Anzambuja MFA, Da Silva D, Bragatti JA, Jacoby T, Saldanha TF. Renal failure is a risk factor for cefepime-induced encephalopathy. J Nephrol. 2008;21:526\u20133.","journal-title":"J Nephrol"},{"key":"1856_CR14","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1345\/aph.1D322","volume":"38","author":"S Abanades","year":"2004","unstructured":"Abanades S, Nolla J, Rodr\u00edguez-Campello A, Pedro C, Valls A, Farr\u00e9 M. Reversible coma secondary to cefepime neurotoxicity. Ann Pharmacother. 2004;38:606\u20138.","journal-title":"Ann Pharmacother"},{"key":"1856_CR15","doi-asserted-by":"publisher","unstructured":"Balderia PG, Chandorkar A, Kim Y, Patnaik S, Sloan J, Newman GC. Dosing cefepime for renal function does not completely prevent neurotoxicity in a patient with kidney transplant. J Patient Saf. 2015. doi: 10.1097\/PTS.0000000000000225 .","DOI":"10.1097\/PTS.0000000000000225"},{"key":"1856_CR16","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/jac\/dkn256","volume":"62","author":"J Bresson","year":"2008","unstructured":"Bresson J, Paugam-Burtz C, Josserand J, Bardin C, Mantz J, Pease S. Cefepime overdosage with neurotoxicity recovered by high-volume haemofiltration. J Antimicrob Chemother. 2008;62:849\u201350.","journal-title":"J Antimicrob Chemother"},{"key":"1856_CR17","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1212\/01.wnl.0000187079.12413.6a","volume":"65","author":"FJ Capparelli","year":"2005","unstructured":"Capparelli FJ, Diaz MF, Hlavnika A, Wainsztein NA, Leiguarda R, Del Castillo ME. Cefepime- and cefiximeinduced encephalopathy in a patient with normal renal function. Neurology. 2005;65:1840.","journal-title":"Neurology"},{"key":"1856_CR18","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ijid.2003.09.003","volume":"8","author":"GK Dakdouki","year":"2004","unstructured":"Dakdouki GK, Al-Awar GN. Cefepime-induced encephalopathy. Int J Infect Dis. 2004;8:59\u201361.","journal-title":"Int J Infect Dis"},{"key":"1856_CR19","doi-asserted-by":"crossref","first-page":"388","DOI":"10.5414\/CNP59388","volume":"59","author":"N Ferrara","year":"2003","unstructured":"Ferrara N, Abete P, Giordano M, Ferrara P, Carnovale V, Leosco D, et al. Neurotoxicity induced by cefepime in a very old hemodialysis patient. Clin Nephrol. 2003;59:388\u201390.","journal-title":"Clin Nephrol"},{"key":"1856_CR20","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3109\/00365548.2011.581308","volume":"43","author":"VGR Gangireddy","year":"2011","unstructured":"Gangireddy VGR, Mitchell LC, Coleman T. Cefepime neurotoxicity despite renal adjusted dosing. Scand J Infect Dis. 2011;43:827\u20139.","journal-title":"Scand J Infect Dis"},{"key":"1856_CR21","doi-asserted-by":"crossref","first-page":"85","DOI":"10.14581\/jer.14018","volume":"4","author":"J Kwon","year":"2014","unstructured":"Kwon J, Choi JY, Bae EK. Cefepime-induced aphasic status epilepticus mimicking acute stroke. J Epilepsy Res. 2014;4:85\u20137.","journal-title":"J Epilepsy Res"},{"key":"1856_CR22","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1592\/phco.26.8.1169","volume":"26","author":"S Lam","year":"2006","unstructured":"Lam S, Gomolin IH. Cefepime neurotoxicity: case report, pharmacokinetic considerations, and literature review. Pharmacotherapy. 2006;26:1169\u201374.","journal-title":"Pharmacotherapy"},{"key":"1856_CR23","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3904\/kjim.2012.27.3.367","volume":"27","author":"JY Lee","year":"2012","unstructured":"Lee JY, Kang KP, Kim W, Park SK, Lee S. An overlooked cause of impaired consciousness in a hemodialysis patient. Korean J Intern Med. 2012;27:367.","journal-title":"Korean J Intern Med"},{"key":"1856_CR24","doi-asserted-by":"crossref","first-page":"E18","DOI":"10.1002\/jhm.408","volume":"5","author":"H Lichaa","year":"2010","unstructured":"Lichaa H, Rachoin JS, Cerceo E, Rajput V, Surkis W. Cefepime: an underrecognized cause of nonconvulsive status epilepticus. J Hosp Med. 2010;5:E18\u20139.","journal-title":"J Hosp Med"},{"key":"1856_CR25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jcma.2011.01.017","volume":"74","author":"CJ Lin","year":"2011","unstructured":"Lin CJ, Chen SP, Wang SJ, Fuh JL. Cefepime-related encephalopathy in peritoneal dialysis patients. J Chin Med Assoc. 2011;74:87\u201390.","journal-title":"J Chin Med Assoc"},{"key":"1856_CR26","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.yebeh.2005.09.010","volume":"8","author":"R Maganti","year":"2006","unstructured":"Maganti R, Jolin D, Rishi D, Biswas A. Nonconvulsive status epilepticus due to cefepime in a patient with normal renal function. Epilepsy Behav. 2006;8:312\u20134.","journal-title":"Epilepsy Behav"},{"key":"1856_CR27","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1445-5994.2012.02800.x","volume":"42","author":"A McNally","year":"2012","unstructured":"McNally A, Pithie A, Jardine D. Cefepime: a rare cause of encephalopathy. Intern Med J. 2012;42:732\u20133.","journal-title":"Intern Med J"},{"key":"1856_CR28","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/sj.bmt.1704314","volume":"33","author":"E Plensa","year":"2004","unstructured":"Plensa E, Gallardo E, Ribera JM, Batlle M, Oriol A, Costa J. Nonconvulsive status epilepticus associated with cefepime in a patient undergoing autologous stem cell transplantation. Bone Marrow Transplant. 2004;33:119\u201320.","journal-title":"Bone Marrow Transplant"},{"key":"1856_CR29","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1159\/000077370","volume":"49","author":"A Primavera","year":"2004","unstructured":"Primavera A, Cocito L, Audenino D. Nonconvulsive status epilepticus during cephalosporin therapy. Neuropsychobiology. 2004;49:218\u201322.","journal-title":"Neuropsychobiology"},{"key":"1856_CR30","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1179\/joc.2009.21.4.452","volume":"21","author":"T Shaheen","year":"2009","unstructured":"Shaheen T, Volles D, Calland F, Sifri CD, Mytinger J, Hagspiel K, et al. Cefepime-associated status epilepticus in an ICU patient with renal failure. J Chemother. 2009;21:452\u20134.","journal-title":"J Chemother"},{"key":"1856_CR31","first-page":"312","volume":"14","author":"NL Smith","year":"2012","unstructured":"Smith NL, Freebairn RC, Park MA, Wallis SC, Roberts JA, Lipman J. Therapeutic drug monitoring when using cefepime in continuous renal replacement therapy: seizures associated with cefepime. Crit Care Resusc. 2012;14:312\u20135.","journal-title":"Crit Care Resusc"},{"key":"1856_CR32","doi-asserted-by":"crossref","first-page":"39","DOI":"10.14581\/jer.13008","volume":"3","author":"A Kim","year":"2013","unstructured":"Kim A, Kim JE, Paek YM, Hong KS, Cho YJ, Cho JY, et al. Cefepime-induced non-convulsive status epilepticus (NCSE). J Epilepsy Res. 2013;3:39\u201341.","journal-title":"J Epilepsy Res"},{"key":"1856_CR33","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s12028-008-9166-8","volume":"10","author":"F Thabet","year":"2009","unstructured":"Thabet F, Al Maghrabi M, Al Barraq A, Tabarki B. Cefepime-induced nonconvulsive status epilepticus: case report and review. Neurocrit Care. 2009;10:347\u201351.","journal-title":"Neurocrit Care"},{"key":"1856_CR34","doi-asserted-by":"crossref","first-page":"450","DOI":"10.47102\/annals-acadmedsg.V36N6p450","volume":"36","author":"DA Silva De","year":"2007","unstructured":"De Silva DA, Pan AB, Lim SH. Cefepime-induced encephalopathy with triphasic waves in three Asian patients. Ann Acad Med Singap. 2007;36:450\u20131.","journal-title":"Ann Acad Med Singap"},{"key":"1856_CR35","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0002-9343(01)00767-7","volume":"111","author":"JE Mart\u00ednez-Rodr\u00edguez","year":"2001","unstructured":"Mart\u00ednez-Rodr\u00edguez JE, Barriga FJ, Santamaria J, Iranzo A, Pareja JA, Revilla M, et al. Nonconvulsive status epilepticus associated with cephalosporins in patients with renal failure. Am J Med. 2001;111:115\u20139.","journal-title":"Am J Med"},{"key":"1856_CR36","first-page":"1026","volume":"22","author":"M Yadla","year":"2011","unstructured":"Yadla M, Kishore CK, Sriramnaveen P, Reddy YS, Sainaresh VV, Bhuma V, et al. Neurotoxicity due to cefepime in patients on maintenance hemodialysis. Saudi J Kidney Dis Transpl. 2011;22:1026\u20137.","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"1856_CR37","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1212\/WNL.54.11.2153","volume":"54","author":"S Dixit","year":"2000","unstructured":"Dixit S, Kurle P, Buyan-Dent L, Sheth RD. Status epilepticus associated with cefepime. Neurology. 2000;54:2153\u20135.","journal-title":"Neurology"},{"key":"1856_CR38","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1111\/j.1528-1167.2005.16305.x","volume":"46","author":"JL Fern\u00e1ndez-Torre","year":"2005","unstructured":"Fern\u00e1ndez-Torre JL, Mart\u00ednez-Mart\u00ednez M, Gonz\u00e1lez-Rato J, Maestro I, Alonso I, Rodrigo E, et al. Cephalosporin-induced nonconvulsive status epilepticus: clinical and electroencephalographic features. Epilepsia. 2005;46:1550\u20132.","journal-title":"Epilepsia"},{"key":"1856_CR39","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1592\/phco.23.3.369.32100","volume":"23","author":"KM Chow","year":"2003","unstructured":"Chow KM, Szeto CC, Hui AC, Wong TY, Li PK. Retrospective review of neurotoxicity induced by cefepime and ceftazidime. Pharmacotherapy. 2003;23:369\u201373.","journal-title":"Pharmacotherapy"},{"key":"1856_CR40","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s10072-012-1001-5","volume":"34","author":"UK Misra","year":"2013","unstructured":"Misra UK, Kalita J, Chandra S, Nair PP. Association of antibiotics with status epilepticus. Neurol Sci. 2013;34:327\u201331.","journal-title":"Neurol Sci"},{"key":"1856_CR41","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/ndt\/gfm713","volume":"23","author":"J Sonck","year":"2008","unstructured":"Sonck J, Laureys G, Verbeelen D. The neurotoxicity and safety of treatment with cefepime in patients with renal failure. Nephrol Dial Transplant. 2008;23:966\u201370.","journal-title":"Nephrol Dial Transplant"},{"key":"1856_CR42","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s11096-013-9799-3","volume":"35","author":"A Tanaka","year":"2013","unstructured":"Tanaka A, Takechi K, Watanabe S, Tanaka M, Suemaru K, Araki H. Comparison of the prevalence of convulsions associated with the use of cefepime and meropenem. Int J Clin Pharm. 2013;35:683\u20137.","journal-title":"Int J Clin Pharm"},{"key":"1856_CR43","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3109\/00365548.2013.878032","volume":"46","author":"T Ugai","year":"2014","unstructured":"Ugai T, Morisaki K, Tsuda K, Sugihara H, Nishida Y, Yamakura M, et al. Cefepime-induced encephalopathy in patients with haematological malignancies: clinical features and risk factors. Scand J Infect Dis. 2014;46:272\u20139.","journal-title":"Scand J Infect Dis"},{"key":"1856_CR44","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0987-7053(00)00234-3","volume":"30","author":"P Jallon","year":"2000","unstructured":"Jallon P, Fankhauser L, Du Pasquier R, Coeytaux A, Picard F, Hefft S, et al. Severe but reversible encephalopathy associated with cefepime. Neurophysiol Clin. 2000;30:383\u20136.","journal-title":"Neurophysiol Clin"},{"key":"1856_CR45","doi-asserted-by":"crossref","first-page":"R51","DOI":"10.1186\/cc8941","volume":"14","author":"TM Chapuis","year":"2010","unstructured":"Chapuis TM, Giannoni E, Majcherczyk PA, Chiol\u00e9ro R, Schaller MD, Berger MM, et al. Prospective monitoring of cefepime in intensive care unit adult patients. Crit Care. 2010;14:R51.","journal-title":"Crit Care"},{"key":"1856_CR46","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jiac.2015.10.009","volume":"22","author":"NJ Rhodes","year":"2016","unstructured":"Rhodes NJ, Kuti JL, Nicolau DP, Neely MN, Nicasio AM, et al. An exploratory analysis of the ability of a cefepime trough concentration greater than 22\u00a0mg\/L to predict neurotoxicity. J Infect Chemother. 2016;22:78\u201383.","journal-title":"J Infect Chemother"},{"key":"1856_CR47","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1212\/WNL.0000000000002455","volume":"86","author":"S Bhattacharyya","year":"2016","unstructured":"Bhattacharyya S, Darby RR, Raibagkar P, Castro LNG, Berkowitz AL. Antibiotic-associated encephalopathy. Neurology. 2016;86:963\u201371.","journal-title":"Neurology"},{"key":"1856_CR48","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/nm.3407","volume":"19","author":"B Obermeier","year":"2013","unstructured":"Obermeier B, Daneman R, Ransohoff RM. Development, maintenance and disruption of the blood\u2013brain barrier. Nat Med. 2013;19:1584\u201396.","journal-title":"Nat Med"},{"issue":"5","key":"1856_CR49","first-page":"295","volume":"58","author":"AB Hill","year":"1965","unstructured":"Hill AB. The environment and disease: association or causation? Proc R Soc Med. 1965;58(5):295\u2013300.","journal-title":"Proc R Soc Med"},{"issue":"1","key":"1856_CR50","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/s13054-016-1522-z","volume":"20","author":"K Cha\u00efbi","year":"2016","unstructured":"Cha\u00efbi K, Chaussard M, Soussi S, Lafaurie M, Legrand M. Not all \u03b2-lactams are equal regarding neurotoxicity. Crit Care. 2016;20(1):350.","journal-title":"Crit Care"},{"key":"1856_CR51","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1001\/archneurol.2011.204","volume":"68","author":"G Naeije","year":"2011","unstructured":"Naeije G, Lorent S, Vincent JL, Legros B. Continuous epileptiform discharges in patients treated with cefepime or meropenem. Arch Neurol. 2011;68:1303.","journal-title":"Arch Neurol"},{"issue":"4","key":"1856_CR52","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/jac\/dkt450","volume":"69","author":"HM Nguyen","year":"2014","unstructured":"Nguyen HM, Shier KL, Graber CJ. Determining a clinical framework for use of cefepime and \u03b2-lactam\/\u03b2-lactamase inhibitors in the treatment of infections caused by extended-spectrum-\u03b2-lactamase-producing Enterobacteriaceae. J Antimicrob Chemother. 2014;69(4):871\u201380.","journal-title":"J Antimicrob Chemother"},{"key":"1856_CR53","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1186\/s13054-014-0674-y","volume":"18","author":"K Hosokawa","year":"2014","unstructured":"Hosokawa K, Gaspard N, Fuhong S, Oddo M, Vincent JL, Taccone FS. Clinical neurophysiological assessment of sepsis-associated brain dysfunction: a systematic review. Crit Care. 2014;18:674.","journal-title":"Crit Care"},{"issue":"6","key":"1856_CR54","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S1474-4422(14)70017-1","volume":"13","author":"CN Widmann","year":"2014","unstructured":"Widmann CN, Heneka MT. Long-term cerebral consequences of sepsis. Lancet Neurol. 2014;13(6):630\u20136.","journal-title":"Lancet Neurol"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-017-1856-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T13:21:00Z","timestamp":1693228860000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-017-1856-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,14]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1856"],"URL":"https:\/\/doi.org\/10.1186\/s13054-017-1856-1","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,14]]},"article-number":"276"}}